The evidence for early intervention

Rheumatic Disease Clinics of North America

Volumn 31, Issue 4, 2005, Pages 575-589

  Quinn, Mark A ^a   Cox, Sally ^a  

^a CHAPEL ALLERTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANALGESIC AGENT; AZATHIOPRINE; C REACTIVE PROTEIN; CHLOROQUINE; CORTICOSTEROID; CYCLOSPORIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GOLD; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PREDNISONE; SALAZOSULFAPYRIDINE; STEROID;

BONE ATROPHY; CLINICAL TRIAL; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG TOLERABILITY; EVIDENCE BASED MEDICINE; HUMAN; IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PUBLICATION; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SCORING SYSTEM; SEROLOGY;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; EARLY DIAGNOSIS; EVIDENCE-BASED MEDICINE; HUMANS;

EID: 27744587808     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2005.07.001     Document Type: Review

References (80)

1. P. Emery, and M. Salmon Early rheumatoid arthritis: time to aim for remission? Ann Rheum Dis 54 1995 944 947
2. M.A. Quinn, and P. Emery Window of opportunity in early rheumatoid arthritis: possibility of altering the disease process with early intervention Clin Exp Rheum 21 Suppl 31 2003 S154 S157
3. K. Aho, M. Heliövaara, and J. Maatela Rheumatoid factors antedating clinical rheumatoid arthritis J Rheumatol 18 1991 1282 1284
4. M.J. Nielen, D. van Schaardenburg, and H.W. Reesink Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors Arthritis Rheum 50 2004 380 386
5. M.J. Nielen, D. van Schaardenburg, and H.W. Reesink Increased levels of C-reactive protein in serum from blood donors before the onset of rheumatoid arthritis Arthritis Rheum 50 2004 2423 2427
6. E. Berglin, L. Padyukov, and U. Sundin A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA DRB-1 locus antigens is strongly associated with future onset of rheumatoid arthritis Arthritis Res Ther 6 2004 R303 R308
7. L. Padyukov, C. Silva, and P. Stolt A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis Arthritis Rheum 50 2004 3085 3092
8. P. Stolt, C. Bengtsson, and B. Nordmark Quantification of the influence of cigarette smoking on the rheumatoid arthritis: results from a population based case-control, using incident cases Ann Rheum Dis 62 2003 835 841
9. P.G. Conaghan, R.J. Wakefield, and P. O'Connor MCPJ assessment in early RA: a comparison between x-ray, MRI, high-resolution ultrasound and clinical examination Arthritis Rheum 41 Suppl 1998 S246
10. R.J. Wakefield, M.J. Green, and W.W. Gibbon High resolution ultrasound defined subclinical synovitis-a predictor of outcome in early oligoarthritis? Arthritis Rheum 41 Suppl 1998 S246
11. M.C. Kraan, H. Versendaal, and M. Jonker Asymptomatic synovitis precedes clinically manifest arthritis Arthritis Rheum 41 1998 1481 1488
12. F.C. Arnett, S.M. Edworthy, and D.A. Bloch The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 31 1988 315 324
13. M. Green, H. Marzo-Ortega, and D. McGonagle Persistence of mild, early inflammatory arthritis: the importance of disease duration, rheumatoid factor and the shared epitope Arthritis Rheum 42 1999 2184 2188
14. A. Calin, and S. Marks The case against sero-negative rheumatoid arthritis Am J Med 70 1981 992 994
15. E.J. Tunn, and P.A. Bacon Differentiating persistent from self-limiting symmetrical synovitis in an early arthritis clinic Br J Rheum 32 1993 97 103
16. H. Visser, S. Cessie, and K. Vos How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis Arthritis Rheum 46 2002 357 365
17. J. Devlin, A. Gough, and A. Huissoon The acute phase and function in early RA: CRP levels correlate with functional outcome J Rheumatol 24 1997 9 13
18. A.K. Gough, J. Lilley, and S. Eyre Generalised bone loss in patients with early RA occurs early and relates to disease activity Lancet 344 1994 23 27
19. A. Deodhar, J. Brabyn, and P.W. Jones Longitudinal study of hand bone densitometry in rheumatoid arthritis Arthritis Rheum 38 1995 1204 1210
20. J. Devlin, J. Lilley, and A. Gough Clinical associations with DXA measurement of hand bone mass in rheumatoid arthritis Br J Rheumatol 35 1996 1256 1262
21. P. Hannonen, T. Mottenen, M. Hakola, and M. Oka Sulfasalazine in early rheumatoid arthritis: a 48 week double-blind, prospective, placebo-controlled study Arthritis Rheum 36 1993 1501 1509
22. I. Van der Horst-Bruinsma, I. Speyer, and H. Visser Diagnosis and course of early-onset arthritis: results of a special early arthritis clinic compared to routine patient care Br J Rheumatol 37 1998 1084 1088
23. D. McGonagle, P.G. Conaghan, and P. O'Connor The relationship between synovitis and bone changes in early untreated rheumatoid arthritis Arthritis Rheum 42 1999 1706 1711
24. R.J. Wakefield, D. McGonagle, and M.J. Green A comparison of high resolution sonography with MRI and conventional radiography for the detection of erosions in early rheumatoid arthritis Br J Rheumatol 37 Suppl 1998 105
25. R.S. Pinals, A.T. Masi, and R.A. Larsen Preliminary criteria for clinical remission in rheumatoid arthritis Arthritis Rheum 24 1981 1138 1142
26. B.J. Harrison, D.P.M. Symmons, and P. Brennan Natural remission in inflammatory polyarthritis: issues of definition and prediction Br J Rheumatol 35 1996 1096 1100
27. K. Eberhardt, and E. Fex Clinical course and remission rate in patients with early rheumatoid arthritis: relationship to outcome after 5 years Br J Rheumatol 37 1998 1324 1329
28. D. McGonagle, W.W. Gibbon, and P. O'Connor An anatomical explanation for good prognosis rheumatoid arthritis Lancet 353 1999 123 124
29. M.A. Van Leeuwen, M.H. Van Rijswijk, and W.J. Sluiter Individual relationship between progression of radiological damage and the acute phase response in early rheumatoid arthritis: towards development of a decision support system J Rheumatol 24 1997 20 27
30. E. Fex, K. Eberhardt, and T. Saxne Tissue derived macromolecules and markers of inflammation in serum in early rheumatoid arthritis: relationship to development of joint destruction in hands and feet Br J Rheumatol 36 1997 1161 1165
31. R.A. Amos, T.J. Constable, and R.A. Crockson Rheumatoid arthritis: relationship of C-reactive protein and erythrocyte sedimentation rates and radiographic change BMJ 1 1977 195 197
32. A.A.M.E. Stenger, M.A. Van Leuewen, and P.M. Houtman Early effective suppression of inflammation in rheumatoid arthritis reduces radiographic progression Br J Rheumatol 37 1998 1157 1163
33. P.T. Dawes, P.D. Fowler, and S. Clarke Rheumatoid arthritis: treatment which controls the C-reactive protein and erythrocyte sedimentation rate reduces radiological progression Br J Rheumatol 25 1986 44 49
34. P. Emery The optimal management of early rheumatoid arthritis: the key to preventing disability Br J Rheumatol 33 1994 765 768
35. P.G. Conaghan, P. O'Connor, and D. McGonagle Elucidation of the relationship between synovitis and bone damage: a randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis Arthritis Rheum 48 2003 64 71
36. D. Mulherin, O. Fitzgerald, and B. Bresnihan Clinical improvement and radiological deterioration in rheumatoid arthritis: evidence that the pathogenesis of synovial inflammation and articular damage may differ Br J Rheumatol 35 1996 1263 1268
37. M. Østergaard, M. Hansen, and M. Stoltenberg New radiographic bone erosions in the wrists of patients with rheumatoid arthritis are detectable with magnetic resonance imaging a median of two years earlier Arthritis Rheum 48 2003 2128 2131
38. R. Munro, R. Hampson, and A. McEntergart Improved functional outcome in patients with early rheumatoid arthritis treated with intramuscular gold: results of a five year prospective study Ann Rheum Dis 57 1998 88 93
39. J.J. Anderson, G. Wells, A.C. Verhoeven, and D.T. Felson Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration Arthritis Rheum 43 2000 22 29
40. D. Symmons, M.A. Jones, D.L. Scott, and P. Prior Long term mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well J Rheumatol 25 1998 1072 1077
41. J.F. Fries, C.A. Williams, and D.A. Bloch The relative toxicity of non-steroidal antiinflammatory drugs Arthritis Rheum 34 1991 1353 1360
42. J.F. Fries, C.A. Williams, D. Ramey, and D.A. Bloch The relative toxicity of disease-modifying antirheumatic drugs Arthritis Rheum 36 1993 297 306
43. J. Fries, C.A. Williams, and D. Morfield Reduction in long-term disability in patients with rheumatoid arthritis by disease-modifying antirheumatic drug-based treatment strategies Arthritis Rheum 39 1996 616 622
44. M. Abu-Shakra, R. Toker, and D. Flusser Clinical and radiographic outcomes of rheumatoid arthritis patients not treated with disease modifying drugs Arthritis Rheum 41 1998 1190 1195
45. C.M. Stein, and T. Pincus Placebo-controlled studies in rheumatoid arthritis: ethical issues Lancet 353 1999 400 403
46. W.D. Schwieterman FDA perspective on anti-TNF treatments Ann Rheum Dis 58 1999 190 191
47. The Australian Multicentre clinical trial group Sulfasalazine in early RA J Rheumatol 19 1992 1672 1677
48. M.J. Davis, P.T. Dawes, and P.D. Fowler Should disease modifying drugs be used in mild rheumatoid arthritis? Br J Rheumatol 30 1991 451 454
49. The HERA study group A randomised trial of hydroxychloroquine in early rheumatoid arthritis: the HERA study Am J Med 98 1995 156 168
50. C. Egsmose, B. Lund, and G. Borg Patients with early arthritis benefit from early 2nd line therapy: 5 year follow-up of a prospective double blind placebo controlled study J Rheumatol 22 1995 2208 2213
51. J.C. Buckland-Wright, G.S. Clarke, I.C. Chikanza, and R. Grahame Quantitative microfocal radiography detects changes in erosion area in patients with early rheumatoid arthritis treated with myocrisine J Rheumatol 20 1993 243 247
52. A. Van der Heide, J.W.G. Jacobs, and J.W.J. Bijlsma The effectiveness of early treatment with 'second-line' anti-rheumatic drugs: a randomised controlled trial Ann Intern Med 124 1996 699 707
53. D.M. Van der Heijde, P.L. Van Riel, and I.H. Nuver-Zwart Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis Lancet 1 1989 1036 1038
54. I.H. Nuver-Zwart, P.L.C.M. Van Riel, L.B.A. Van de Putte, and F.W.J. Gribnau A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine Ann Rheum Dis 48 1989 389 395
55. B.E. Van den Borne, R.B. Landewe, and H.S. The Low dose cyclosporin in early rheumatoid arthritis: effective and safe after two years of therapy when compared to chloroquine Scand J Rheumatol 25 1996 307 316
56. H.K. Zeidler, T.K. Kvien, and P. Hannonen Progression of joint damage in early active severe rheumatoid arthritis during eighteen months of treatment: comparison of low dose cyclosporin and parenteral gold Br J Rheumatol 37 1998 874 882
57. R. Peltomaa, L. Paimela, T. Helve, and M. Leirisalo-Repo Comparison of intramuscular gold and sulphasalazine in the treatment of early rheumatoid arthritis: a one year prospective study Scand J Rheumatol 24 1995 330 335
58. H. Menninger, G. Herborn, and O. Sander A 36 month comparative trial of methotrexate and gold sodium thiomalate in the treatment of early active and erosive rheumatoid arthritis Br J Rheumatol 37 1998 1060 1068
59. R. Rau, G. Herborn, and T. Karger Progression in early erosive rheumatoid arthritis: 12 month results from a randomised controlled trial comparing methotrexate and gold sodium thiomalate Br J Rheumatol 37 1998 1220 1226
60. C.H.M. Van Jaarsveld, J.W.G. Jacobs, and M.J. van der Veen Aggressive treatment in early rheumatoid arthritis: a randomised controlled trial Ann Rheum Dis 59 2000 468 477
61. J.S. Smolen, J.K. Kalden, and D.L. Scott Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial Lancet 353 1999 259 266
62. V. Strand, S. Cohen, M. Schiff for the Leflunomide Rheumatoid Arthritis investigators group Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate Arch Intern Med 159 1999 2542 2550
63. A.C. Verhoeven, M. Boers, and P. Tugwell Combination therapy in rheumatoid arthritis: updated systematic review Br J Rheumatol 37 1998 612 619
64. M. Dougados, B. Combe, and A. Cantagrel Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components Ann Rheum Dis 58 1999 220 225
65. C.J. Haagsma, P.L.C.M. Van Riel, A.J.L. De Jong, and L.B.A. Van de Putte Combination of sulphasalzine and methotrexate versus the single components in early rheumatoid arthritis: a randomised, controlled, double-blind, 52 week clinical trial Br J Rheumatol 36 1997 1082 1088
66. T. Mottenen, P. Hannonen, and M. Leirisalo-Repo Comparison of combination therapy with single drug-therapy in early rheumatoid arthritis: a randomised trial Lancet 353 1999 1568 1573
67. M. Boers, A.C. Verhoeven, and H.M. Markusse Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis Lancet 350 1997 309 318
68. A.C. Verhoeven, J.C. Bibo, M. Boers for the COBRA trial group Cost-effectiveness and cost-utility of combination therapy in early rheumatoid arthritis: randomized comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone Br J Rheumatol 37 1998 1102 1109
69. R.B. Landewe, M. Boers, and A.C. Verhoeven COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention Arthritis Rheum 46 2002 347 356
70. S. Proudman, P. Conaghan, and C. Richardson Treatment of poor prognosis early rheumatoid arthritis a randomised study of methotrexate, cyclosporin A and intraarticular corticosteroids compared with sulphasalazine alone Arthritis Rheum 43 2000 1809 1819
71. C. Grigor, H. Capell, and A. Stirling Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised study Lancet 364 2004 263 269
72. J.R. Kirwan and the ARC Low dose glucocorticoid study group The effect of glucocorticoids on joint destruction in rheumatoid arthritis N Engl J Med 333 1995 142 146
73. P. Hickling, R.K. Jacoby, J.R. Kirwan and the Arthritis and Rheumatism Council low dose glucocorticosteroid group Joint destruction after glucocorticoids are withdrawn in early rheumatoid arthritis Br J Rheum 37 1998 930 936
74. J.M. Bathon, R.W. Martin, and R.M. Fleischmann A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis N Engl J Med 343 2000 1586 1593
75. P.E. Lipsky, D.M.F.M. van der Heijde, and E.W. St. Clair Infliximab and methotrexate in the treatment of rheumatoid arthritis N Engl J Med 343 2000 1594 1602
76. F.C. Breedveld, P. Emery, and E. Keystone Infliximab in active early rheumatoid arthritis Ann Rheum Dis 63 2004 149 155
77. E.W. St Clair, D.M. van der Heijde, and J.S. Smolen Combination of infliximab and methotrextae therapy for early rheumatoid arthritis: a randomised controlled trial Arthritis Rheum 50 2004 3432 3443
78. M.A. Quinn, P.G. Conaghan, and A. Greenstein Very early infliximab in addition to methotrexate in early poor prognosis rheumatoid arthritis reduces MRI synovitis and damage with sustained benefit after infliximab withdrawal: results from a double blind placebo-controlled trial Arthritis Rheum 52 2005 27 35
79. J.K. De Vries-Bouwstra, Y.P.M. Goekoop-Ruiterman, and D. van Zeben A comparison of clinical and radiological outcomes of four treatment strategies for early rheumatoid arthritis: results of the BEST trial Ann Rheum Dis 63 Suppl 2004 58
80. F.C. Breedveld, A. Kavanaugh, and S. Cohen Early treatment of rheumatoid arthritis with adalimumab plus methotrexate versus adalimumab alone or methotrexate alone: the PREMIER study Arthritis Rheum 50 2004 4096 4097